p53 peptides in Montanide adjuvant

This vaccine was used in patients with colorectal cancer or ovarium cancer. It was well tolerated and robust p53-specific T cell responses were induced.

created over 15 years ago (5 February 2010)    last modified over 13 years ago (28 September 2011)   [ RDF ]   [ RelFinder ]